Statements (56)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:species
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:Plasmodium
|
gptkbp:belongs_to |
genus Plasmodium
|
gptkbp:caused_by |
malaria
|
gptkbp:controls |
case management
surveillance vector control |
gptkbp:coordinates |
gptkb:Anopheles_mosquitoes
|
gptkbp:discovered_by |
gptkb:Sir_Ronald_Ross
|
gptkbp:disease_resistance |
emerging resistance
|
gptkbp:distribution |
tropical regions
|
gptkbp:duration |
3 days
|
gptkbp:first_described_by |
1880
|
gptkbp:has_feature |
trophozoite stage
gametocyte stage ring stage schizont stage |
gptkbp:healthcare |
WHO initiatives
malaria elimination strategies global malaria eradication efforts |
gptkbp:hosts |
gptkb:Person
mosquitoes |
https://www.w3.org/2000/01/rdf-schema#label |
Plasmodium malariae
|
gptkbp:impact |
morbidity and mortality
economic burden public health issue |
gptkbp:is_a |
species of Plasmodium
|
gptkbp:is_protected_by |
insecticide-treated nets
antimalarial prophylaxis indoor spraying |
gptkbp:is_vulnerable_to |
ongoing studies
no effective vaccine available |
gptkbp:lifespan |
complex life cycle
|
gptkbp:related_to |
gptkb:Plasmodium_falciparum
gptkb:Plasmodium_vivax gptkb:Plasmodium_ovale |
gptkbp:research |
studied for vaccine development
|
gptkbp:seed_dispersal |
~23 million base pairs
|
gptkbp:social_responsibility |
seasonal outbreaks
endemic in some regions blood smear rapid diagnostic tests asymptomatic carriers |
gptkbp:symptoms |
headache
muscle pain nausea fever vomiting 1-2 weeks chills sweats |
gptkbp:transmission |
mosquito bites
|
gptkbp:treatment |
gptkb:chloroquine
gptkb:primaquine antimalarial drugs |